CMS and FDA launch RAPID Medicare coverage pathway for devices

CMS and the FDA launched the RAPID Medicare coverage pathway for devices, creating a faster route to reimbursement for qualifying medical technologies. The policy should improve commercialization timelines and reduce coverage uncertainty for device makers, making it a constructive regulatory development for the healthcare innovation sector.

Analysis

CMS and the FDA launched the RAPID Medicare coverage pathway for devices, creating a faster route to reimbursement for qualifying medical technologies. The policy should improve commercialization timelines and reduce coverage uncertainty for device makers, making it a constructive regulatory development for the healthcare innovation sector.